Rachel Burgoon, PharmD


Increase in Enteroviruses Seen with Decreases in COVID-19 Precautions

The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.

Carl V. Crawford, MD


Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

Monica Gandhi, MD, MPH


High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.

Robert Bettiker, MD/MGA, FACP


Resolution of Scurvy in a Patient With a Spinal Cord Injury

At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.

Christina Rose, PharmD, BCCCP


Oral Therapeutic Options to Prevent Disease Progression From COVID-19 in an Ambulatory Setting

As the number of COVID-19 cases continues to rise, oral treatment options for at-home use are in demand to provide early intervention and reduce the progression to severe disease, hospitalization, and death.

Katrine Wallace, PhD


Communication Breakdown: Dissemination of Public Health Information

Imprecise language can fuel infodemics and misinformation and damage public trust.

Ann-Marie Idusuyi, PharmD


Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.

Camilo Mora, PhD


When Climate Change Gets Personal: The Expanding Threat of Mosquito Habitats

As someone who lives with the long-term effects of chikungunya, Camillo Mora PhD, sees the expanding habitat of mosquitos and is concerned more people will be exposed to vector-borne illnesses and deal with not only the acute phases of these viruses but also the possibility of long-term health effects they can present.

Amy Rowley, PharmD


Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public Health

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.

Hawra Al-Lawati, MD


Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.

Krutika Kuppalli, MD, FIDSA; and Syra Madad, DHSc, MSc


Emerging Infectious Diseases During COVID-19

In this era of increasingly mobile and connected populations, it is possible for an infection to spread around the world in 24 to 48 hours.

Andrea Prinzi, PhD, MPH, SM(ASCP)


Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?

The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.

Jordan Mayberry, PA-C, MPAS


The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.

© 2024 MJH Life Sciences

All rights reserved.